Literature DB >> 20179178

Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues.

Antonella Roetto1, Ferdinando Di Cunto, Rosa Maria Pellegrino, Emilio Hirsch, Ornella Azzolino, Alessandro Bondi, Ilaria Defilippi, Sonia Carturan, Barbara Miniscalco, Fulvio Riondato, Daniela Cilloni, Lorenzo Silengo, Fiorella Altruda, Clara Camaschella, Giuseppe Saglio.   

Abstract

Transferrin receptor 2 (TFR2) is a transmembrane protein that is mutated in hemochromatosis type 3. The TFR2 gene is transcribed in 2 main isoforms: the full-length (alpha) and a shorter form (beta). alpha-Tfr2 is the sensor of diferric transferrin, implicated in the modulation of hepcidin, the main regulator of iron homeostasis. The function of the putative beta-Tfr2 protein is unknown. We have developed a new mouse model (KI) lacking beta-Tfr2 compared with Tfr2 knockout mice (KO). Adult Tfr2 KO mice show liver iron overload and inadequate hepcidin levels relative to body iron stores, even though they increase Bmp6 production. KI mice have normal transferrin saturation, liver iron concentration, hepcidin and Bmp6 levels but show a transient anemia at young age and severe spleen iron accumulation in adult animals. Fpn1 is strikingly decreased in the spleen of these animals. These findings and the expression of beta-Tfr2 in wild-type mice spleen suggest a role for beta-Tfr2 in Fpn1 transcriptional control. Selective inactivation of liver alpha-Tfr2 in KI mice (LCKO-KI) returned the phenotype to liver iron overload. Our results strengthen the function of hepatic alpha-Tfr2 in hepcidin activation, suggest a role for extrahepatic Tfr2 and indicate that beta-Tfr2 may specifically control spleen iron efflux.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20179178     DOI: 10.1182/blood-2009-09-240960

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.

Authors:  Carla Casu; Mariateresa Pettinato; Alison Liu; Mariam Aghajan; Vania Lo Presti; Maria Rosa Lidonnici; Kevin A Munoz; Emir O'Hara; Violante Olivari; Simona Maria Di Modica; Sheri Booten; Shuling Guo; Garry Neil; Reem Miari; Nir Shapir; Inbal Zafir-Lavie; Hagit Domev; Giuliana Ferrari; Despina Sitara; Antonella Nai; Stefano Rivella
Journal:  Blood       Date:  2020-10-22       Impact factor: 22.113

Review 2.  Hereditary hemochromatosis and transferrin receptor 2.

Authors:  Juxing Chen; Caroline A Enns
Journal:  Biochim Biophys Acta       Date:  2011-08-16

3.  Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe.

Authors:  Elena Corradini; Molly Rozier; Delphine Meynard; Adam Odhiambo; Herbert Y Lin; Qi Feng; Mary C Migas; Robert S Britton; Jodie L Babitt; Robert E Fleming
Journal:  Gastroenterology       Date:  2011-07-13       Impact factor: 22.682

Review 4.  Iron and erythropoiesis: a dual relationship.

Authors:  Clara Camaschella; Alessia Pagani
Journal:  Int J Hematol       Date:  2010-12-18       Impact factor: 2.490

5.  Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.

Authors:  Maura Poli; Michela Asperti; Annamaria Naggi; Natascia Campostrini; Domenico Girelli; Michela Corbella; Marina Benzi; Celine Besson-Fournier; Helene Coppin; Federica Maccarinelli; Dario Finazzi; Paolo Arosio
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

6.  Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.

Authors:  Aaron M Wortham; Devorah C Goldman; Juxing Chen; William H Fleming; An-Sheng Zhang; Caroline A Enns
Journal:  J Biol Chem       Date:  2020-02-13       Impact factor: 5.157

7.  Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Am J Hematol       Date:  2012-03-28       Impact factor: 10.047

8.  Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors.

Authors:  Ulrike Baschant; Martina Rauner; Ekaterina Balaian; Heike Weidner; Antonella Roetto; Uwe Platzbecker; Lorenz C Hofbauer
Journal:  Haematologica       Date:  2016-08-18       Impact factor: 9.941

Review 9.  Mouse Models of Erythropoiesis and Associated Diseases.

Authors:  Matthew P Parker; Kenneth R Peterson
Journal:  Methods Mol Biol       Date:  2018

Review 10.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.